Law channel feed

The Supreme Court could over­turn the Chevron doc­trine. Here’s how that could hurt the FDA

Last year
Pharma
FDA+

Pfiz­er and BioN­Tech urge US patent re­view board to take on Mod­er­na's Covid patents

Last year
Pharma
Coronavirus

Up­dat­ed: Seagen's ADC patent de­nied by US patent of­fice in bat­tle with Dai­ichi Sankyo

Last year
Pharma

Rav­gen con­tin­ues its le­gal re­venge saga with a $57M ver­dict over Nat­era

Last year
Diagnostics

Am­i­cus briefs fly in as IRA 'fair price' dead­line looms

Last year
Pharma

Econ­o­mists, health pol­i­cy ex­perts say J&J's IRA ar­gu­ments are 'over­ly sim­plis­tic'

Last year
Pharma

Case against Gilead for de­lay­ing re­lease of safer HIV drug on sol­id ground, court rules

Last year

LinkedUp, TianTi end le­gal dis­pute with Adimab over yeast-based an­ti­body plat­form

Last year

PhRMA read­ies suit over Flori­da's new­ly au­tho­rized Cana­di­an drug im­port plan

Last year

Ex­clu­sive: Il­lu­mi­na board mem­bers al­lege ac­tivist di­rec­tor gave con­fi­den­tial in­for­ma­tion to Ic­ahn for use in law­suit

Last year
Diagnostics

Re­vance los­es at­tempt to dis­miss Botox trade se­crets law­suit

Last year
Pharma

Dai­ichi Sankyo set­tles its car­dio drug law­suit with Es­pe­ri­on, which will get $125M mile­stone pay­ment

Last year
Pharma

Yale Law School's free speech group says Boehringer's IRA ar­gu­ment is 'fun­da­men­tal­ly flawed'

Last year
Pharma

Cor­cept los­es patent fight with Te­va over Cush­ing's syn­drome drug

Last year
Pharma

Re­gen­eron scores Eylea patent win against My­lan, keep­ing biosim­i­lar at bay

Last year
Pharma

Servi­er found guilty of fraud in tri­al over pulled weight loss drug Me­di­a­tor, re­vers­ing ear­li­er rul­ing

Last year
Pharma

Ab­b­Vie files trade se­crets suit against Ad­cen­trx and for­mer em­ploy­ee

Last year
Pharma

FTC lays out road map for merg­er re­view in over­haul of decade-old an­titrust frame­work

Last year
Pharma

Ger­man court de­nies va­lid­i­ty of Cure­Vac patent claim in fight with BioN­Tech over Covid-19 vac­cine 

Last year
Pharma

Patent thick­et strat­e­gy with ter­mi­nal dis­claimers helps block bi­o­log­ic com­pe­ti­tion, JA­MA let­ter shows

Last year
FDA+

White House keeps fo­cus on low­er­ing drug prices, turns Re­gen­eron's con­tract lan­guage in­to new stan­dard

Last year
Pharma
FDA+

Sen­ate health com­mit­tee ad­vances changes to how FDA would ap­prove new opi­oids

Last year
FDA+

Supreme Court to re­view lim­i­ta­tions on abor­tion pill

Last year
Pharma

No­vo Nordisk calls IRA 'un­prece­dent­ed de­par­ture' from US Con­sti­tu­tion

Last year
Pharma
First page Previous page 12131415161718 Next page Last page
A service from the Financial Times